A pioneering research group at Barts Cancer Institute, Queen Mary University of London, UK where innovation meets precision in cancer research. Harnessing the power of advanced AI, computer vision, and deep learning, we are redefining the landscape of medical image analysis—transforming how cancer is detected, diagnosed, and treated.

Our mission is to seamlessly integrate data from radiology, histopathology, genomics, and electronic health records, driving forward cutting-edge tools that deliver unprecedented accuracy and clinical insight. By bridging the gap between AI innovation and real-world clinical practice, we are shaping the future of cancer care and paving the way for transformative patient outcomes.